Possible role of more positive social behaviour in the clinical effect of antidepressant drugs

Journal of Psychiatry and Neuroscience

Volumn 39, Issue 1, 2014, Pages 60-65

  Young, Simon N ^a   Moskowitz, Debbie S ^a   aan het Rot, Marije ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; ESCITALOPRAM; FENCLONINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NEUROTRANSMITTER; PAROXETINE; PLACEBO; REBOXETINE; SEDATIVE AGENT; SEROTONIN; SERTRALINE; TRYPTOPHAN;

AGGRESSION; ANXIETY DISORDER; DEPRESSION; EMOTIONAL DISORDER; HUMAN; IRRITABILITY; META ANALYSIS (TOPIC); MOOD DISORDER; NONHUMAN; NOTE; PERSONALITY DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SEROTONIN RELEASE; SINGLE DRUG DOSE; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SYSTEMATIC REVIEW (TOPIC); ANIMAL; DEPRESSIVE DISORDER; METABOLISM; PATHOPHYSIOLOGY; PSYCHOLOGICAL MODEL; PSYCHOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; MODELS, PSYCHOLOGICAL; SEROTONIN; SOCIAL BEHAVIOR;

EID: 84891814455     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.130165     Document Type: Article

References (68)

1. Blier P, El Mansari M. Serotonin and beyond: therapeutics for major depression. Philos Trans R Soc Lond B Biol Sci 2013;368:20120536.
2. Harmer CJ, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 2009;195:102-8.
3. Carrillo M, Ricci LA, Coppersmith GA, et al. The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies. Psychopharmacology (Berl) 2009;205:349-68.
4. Chamberlain B, Ervin FR, Pihl RO, et al. The effect of raising or lowering tryptophan levels on aggression in vervet monkeys. Pharmacol Biochem Behav 1987;28:503-10.
5. Raleigh MJ, Brammer GL, Yuwiler A, et al. Serotonergic influences on the social behavior of vervet monkeys (Cercopithecus aethiops sabaeus). Exp Neurol 1980;68:322-34.
6. Raleigh MJ, Brammer GL, McGuire MT, et al. Dominant social status facilitates the behavioral effects of serotonergic agonists. Brain Res 1985;348:274-82.
7. Young SN. The effect of raising and lowering tryptophan levels on human mood and social behaviour. Philos Trans R Soc Lond B Biol Sci 2013;368:20110375.
8. Morand C, Young SN, Ervin FR. Clinical response of aggressive schizophrenics to oral tryptophan. Biol Psychiatry 1983;18:575-8.
9. Volavka J, Crowner M, Brizer D, et al. Tryptophan treatment of aggressive psychiatric inpatients. Biol Psychiatry 1990;28:728-32.
10. Steinberg S, Annable L, Young SN, et al. A placebo-controlled clin-ical trial of L-tryptophan in premenstrual dysphoria. Biol Psychiatry 1999;45:313-20.
11. Moskowitz DS. Cross-situational generality and the interpersonal circumplex. J Pers Soc Psychol 1994;66:921-33.
12. Brown KW, Moskowitz DS. Dynamic stability of behavior: the rhythms of our interpersonal lives. J Pers 1998;66:105-34.
13. Moskowitz DS, Pinard G, Zuroff DC, et al. The effect of tryptophan on social interaction in every day life: a placebo-controlled study. Neuropsychopharmacology 2001;25:277-89.
14. aan het Rot M, Moskowitz DS, Pinard G, et al. Social behaviour and mood in everyday life: effects of tryptophan in quarrelsome individuals. J Psychiatry Neurosci 2006;31:253-62.
15. Kravitz EA. Serotonin and aggression: insights gained from a lobster model system and speculations on the role of amine neurons in a complex behavior. J Comp Physiol A 2000;186:221-38.
16. Anstey ML, Rogers SM, Ott SR, et al. Serotonin mediates behavioral gregarization underlying swarm formation in desert locusts. Science 2009;323:627-30.
17. Serretti A, Calati R, Goracci A, et al. Antidepressants in healthy subjects: What are the psychotropic/psychological effects? Eur Neuropsychopharmacol 2010;20:433-53.
18. Knutson B, Wolkowitz OM, Cole SW, et al. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 1998;155:373-9.
19. Tse WS, Bond AJ. Serotonergic involvement in the psychosocial dimension of personality. J Psychopharmacol 2001;15:195-8.
20. Tse WS, Bond AJ. Serotonergic intervention affects both social dominance and affiliative behavior. Psychopharmacology (Berl) 2002;161:324-30.
21. Tse WS, Bond AJ. Difference in serotonergic and noradrenergic regulation of human social behaviours. Psychopharmacology (Berl) 2002;159:216-21.
22. Tse WS, Bond AJ. Reboxetine promotes social bonding in healthy volunteers. J Psychopharmacol 2003;17:189-95.
23. Tse WS, Bond AJ. Noradrenaline might enhance assertive human social behaviours: an investigation in a flatmate relationship. Pharmacopsychiatry 2006;39:175-9.
24. Kamarck TW, Haskett RF, Muldoon M, et al. Citalopram intervention for hostility: results of a randomized clinical trial. J Consult Clin Psychol 2009;77:174-88.
25. Simmons JG, Allen NB. Mood and personality effects in healthy participants after chronic administration of sertraline. J Affect Disord 2011;134:377-85.
26. Knorr U, Vinberg M, Mortensen EL, et al. Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial. PLoS ONE 2012;7:e31980.
27. Szabo ST, Blier P. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus. Neuropsychopharmacology 2001;25:845-57.
28. Fava M, Hwang I, Rush AJ, et al. The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Mol Psychiatry 2010;15:856-67.
29. Perlis RH, Fraguas R, Fava M, et al. Prevalence and clinical correl-ates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study. J Clin Psychiatry 2005;66:159-66.
30. Bond AJ. Antidepressant treatments and human aggression. Eur J Pharmacol 2005;526:218-25.
31. Painuly N, Sharan P, Mattoo SK. Relationship of anger and anger attacks with depression. Eur Arch Psychiatry Clin Neurosci 2005;255: 215-22.
32. Fava M, Nierenberg AA, Quitkin FM, et al. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atyp-ical depression and dysthymia. Psychopharmacol Bull 1997;33:101-3.
33. Agosti V, McGrath PJ. Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression. J Affect Disord 2002;71:113-20.
34. Tang TZ, DeRubeis RJ, Hollon SD, et al. Personality change during depression treatment: a placebo-controlled trial. Arch Gen Psychiatry 2009;66:1322-30.
35. Salzman C, Wolfson AN, Schatzberg A, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995;15:23-9.
36. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997;54:1081-8.
37. Rinne T, van den Brink W, Wouters L, et al. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 2002;159:2048-54.
38. Vartiainen H, Tiihonen J, Putkonen A, et al. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr Scand 1995;91:348-51.
39. McDougle CJ, Naylor ST, Cohen DJ, et al. A double-blind, placebocontrolled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996;53:1001-8.
40. Pearlstein T, Yonkers KA, Fayyad R, et al. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord 2005;85:275-82.
41. Shah NR, Jones JB, Aperi J, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 2008;111:1175-82.
42. Landén M, Erlandsson H, Bengtsson F, et al. Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability. Neuropsychopharmacology 2009;34:585-92.
43. Kornstein SG, Pearlstein TB, Fayyad R, et al. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies. J Clin Psychiatry 2006;67:1624-32.
44. Hames JL, Hagan CR, Joiner TE. Interpersonal processes in depression. Annu Rev Clin Psychol. In press.
45. Lara ME, Klein DN. Psychosocial processes underlying the maintenance and persistence of depression: implications for understanding chronic depression. Clin Psychol Rev 1999;19:553-70.
46. Strack S, Coyne JC. Social confirmation of dysphoria: shared and private reactions to depression. J Pers Soc Psychol 1983;44:798-806.
47. Biglan A, Hops H, Sherman L, et al. Problem-solving interactions of depressed women and their husbands. Behav Ther 1985;16:431-51.
48. Hokanson JE, Butler AC. Cluster analysis of depressed college students' social behaviors. J Pers Soc Psychol 1992;62:273-80.
49. Kiesler DJ. The 1982 interpersonal circle: a taxonomy for complementarity in human transactions. Psychol Rev 1983;90:185-214.
50. Tracey TJ. An interpersonal stage model of the therapeutic process. J Couns Psychol 1993;40:396-409.
51. Sadler P, Ethier N, Gunn GR, et al. Are we on the same wavelength? Interpersonal complementarity as shared cyclical patterns during interactions. J Pers Soc Psychol 2009;97:1005-20.
52. Sadler P, Woody E. Is who you are who you're talking to? Interpersonal style and complementarily in mixed-sex interactions. J Pers Soc Psychol 2003;84:80-96.
53. Markey P, Lowmaster S, Eichler W. A real-time assessment of interpersonal complementarity. Pers Relatsh 2010;17:13-25.
54. Markey PM, Funder DC, Ozer DJ. Complementarity of interpersonal behaviors in dyadic interactions. Pers Soc Psychol Bull 2003;29:1082-90.
55. Moskowitz DS. Ho M-hR, Turcotte-Tremblay A-M. Contextual influences on interpersonal complementarity. Pers Soc Psychol Bull 2007; 33: 1051-63.
56. Feeney BC, Cassidy J, Lemay EP, et al. Affiliation with new peer acquaintances during two initial social support interactions. Pers Relatsh 2009;16:489-506.
57. Moskowitz DS, Côté S. Do interpersonal traits predict affect? A comparison of three models. J Pers Soc Psychol 1995;69:915-24.
58. Côté S, Moskowitz DS. On the dynamic covariation between interpersonal behavior and affect: prediction from neuroticism, extraversion, and agreeableness. J Pers Soc Psychol 1998;75:1032-46.
59. Sadikaj G, Moskowitz DS, Russell JJ, et al. Quarrelsome behavior in borderline personality disorder: influence of behavioral and affective reactivity to perceptions of others. J Abnorm Psychol 2013;122:195-207.
60. Watson D, Clark LA. Measurement and mismeasurement of mood: recurrent and emergent issues. J Pers Assess 1997;68:267-96.
61. Crawford JR, Henry JD. The Positive and Negative Affect Schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol 2004;43:245-65.
62. aan het Rot M, Hogenelst K, Schoevers RA. Mood disorders in everyday life: a systematic review of experience sampling and ecological momentary assessment studies. Clin Psychol Rev 2012;32:510-23.
63. Geschwind N, Nicolson NA, Peeters F, et al. Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy. Eur Neuropsychopharmacol 2011; 21:241-7.
64. Wichers M, Lothmann C, Simons CJP, et al. The dynamic interplay between negative and positive emotions in daily life predicts response to treatment in depression: a momentary assessment study. Br J Clin Psychol 2012;51:206-22.
65. Bel N, Artigas F. Chronic treatment with fluvoxamine increases extra cellular serotonin in frontal cortex but not in raphe nuclei. Synapse 1993;15:243-5.
66. Cowen PJ. The effect of tryptophan on brain 5-HT function: a review. Hum Psychopharmacol 1994;9:371-6.
67. Delgado PL, Miller HL, Salomon RM, et al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999;46:212-20.
68. Harmer CJ, Cowen PJ. 'It's the way that you look at it'-a cognitive neuropsychological account of SSRI action in depression. Philos Trans R Soc Lond B Biol Sci 2013;368:20120407.